Health Economics & Policy Analysis Centre, National University of Ireland, Galway, Ireland.
CURAM, Science Foundation Ireland (SFI) Research Centre for Medical Devices, National University of Ireland, Galway, Ireland.
Diabet Med. 2022 May;39(5):e14779. doi: 10.1111/dme.14779. Epub 2022 Jan 4.
Type 1 diabetes is a chronic disease, which given its existing and projected prevalence, is likely to pose a significant economic burden, both in terms of directs costs to the healthcare system and indirect costs to society. We aimed to estimate the economic burden of type 1 diabetes in Ireland, which at present, is unknown.
A cost of illness study was undertaken to estimate the cost of type 1 diabetes in Ireland for 2018. Data for prevalence, morbidity, mortality, healthcare resource use, absenteeism, and unit costs were obtained from national, and where necessary, international sources. Direct healthcare costs were estimated for primary care, outpatient, emergency and inpatient care, for associated complications, structured education programmes, insulin and related care. Additionally, indirect costs from lost earnings due to premature death and employee absenteeism were estimated.
Type 1 diabetes was estimated to cost €129 million in Ireland in 2018, with direct healthcare costs accounting for €81.5 million or 63% and indirect costs for €47.5 million or 37% of the total. On average, this amounted to €3994 per patient in direct healthcare costs and €2326 per patient in indirect costs.
Type 1 diabetes is a leading public health problem. Our study is the first to assess the economic burden of type 1 diabetes in Ireland, and our results should be informative to policymakers tasked with prioritising healthcare and research funding resource allocation.
1 型糖尿病是一种慢性病，鉴于其现有和预计的流行率，它很可能给医疗保健系统带来巨大的经济负担，无论是直接成本还是对社会的间接成本。我们旨在评估爱尔兰 1 型糖尿病的经济负担，目前尚不清楚爱尔兰 1 型糖尿病的经济负担情况。
进行了一项疾病成本研究，以估计 2018 年爱尔兰 1 型糖尿病的成本。患病率、发病率、死亡率、医疗资源使用、旷工和单位成本的数据来自国家和必要时的国际来源。直接医疗成本估计用于初级保健、门诊、急诊和住院治疗、相关并发症、结构化教育计划、胰岛素和相关护理。此外，还估计了由于过早死亡和员工旷工而导致的间接损失。
2018 年，爱尔兰估计 1 型糖尿病的费用为 1.29 亿欧元，其中直接医疗费用占 8150 万欧元或 63%，间接费用占 4750 万欧元或 37%。平均而言，直接医疗费用中每位患者为 3994 欧元，间接费用中每位患者为 2326 欧元。
1 型糖尿病是一个主要的公共卫生问题。我们的研究首次评估了爱尔兰 1 型糖尿病的经济负担，我们的研究结果应该为负责优先分配医疗保健和研究资金资源的政策制定者提供信息。
